Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain

Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain

Show other versions (1)

Epigenetic processes play a key role in the central nervous system and altered levels of 5-methylcytosine have been associated with a number of neurologic phenotypes, including Alzheimer's disease (AD). Recently, 3 additional cytosine modifications have been identified (5-hydroxymethylcytosine,...

Full description

Bibliographic Details
Main Authors:	Condliffe, D, Wong, A, Troakes, C, Proitsi, P, Patel, Y, Chouliaras, L, Fernandes, C, Cooper, J, Lovestone, S, Schalkwyk, L, Mill, J, Lunnon, K
Format:	Journal article
Published:	2014

Similar Items

Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain.
by: Condliffe, D, et al.
Published: (2014)

The role of 5-hydroxymethylcytosine in aging and Alzheimer's disease: current status and prospects for future studies.
by: van den Hove, D, et al.
Published: (2012)

Peripheral DNA methylation, cognitive decline and brain ageing: Pilot findings from the Whitehall II Imaging Study
by: Chouliaras, L, et al.
Published: (2018)

Age-related increase in levels of 5-hydroxymethylcytosine in mouse hippocampus is prevented by caloric restriction.
by: Chouliaras, L, et al.
Published: (2012)

Alterations of 5-Hydroxymethylcytosine in Human Cancers
by: Ali Yesilkanal, et al.
Published: (2013-06-01)

Quantitation and mapping of the epigenetic marker 5-hydroxymethylcytosine
by: Qing, Y, et al.
Published: (2017)

Genome-wide characterization of mitochondrial DNA methylation in human brain
by: Matthew Devall, et al.
Published: (2023-01-01)

The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain.
by: Kriaucionis, S, et al.
Published: (2009)

Conflict management : a practical guide /
by: 465907 Condliffe, Peter
Published: (2002)

Advanced paternal age effects in neurodevelopmental disorders-review of potential underlying mechanisms
by: Janecka, M, et al.
Published: (2017)

5-Methylcytosine and 5-Hydroxymethylcytosine in Scrapie-Infected Sheep and Mouse Brain Tissues
by: Adelaida Hernaiz, et al.
Published: (2023-01-01)

The recognition, generation and detection of 5-hydroxymethylcytosine
by: Bi, Y
Published: (2020)

5-Hydroxymethylcytosine Loss in Conjunctival Melanoma
by: Alexandre Stahl, et al.
Published: (2021-06-01)

Modular oxidation of cytosine modifications and their application in direct and quantitative sequencing of 5-hydroxymethylcytosine
by: Xu, H, et al.
Published: (2023)

An acoustic microscopy technique to assess particle size and distribution following needle-free injection.
by: Condliffe, J, et al.
Published: (2010)

Mitochondrial genes are altered in blood early in Alzheimer's disease
by: Lunnon, K, et al.
Published: (2017)

Covering the bases: Loss of 5-hydroxymethylcytosine in melanoma
by: Kriaucionis, S
Published: (2013)

Covering the bases: Loss of 5-hydroxymethylcytosine in melanoma
by: Kriaucionis, S
Published: (2012)

Regulation and Functional Significance of 5-Hydroxymethylcytosine in Cancer
by: Vittal Rangan Arvinden, et al.
Published: (2017-11-01)

Single-molecule detection of 5-hydroxymethylcytosine in DNA through chemical modification and nanopore analysis.
by: Li, W, et al.
Published: (2013)

Epigenetic landscape of 5-hydroxymethylcytosine and associations with gene expression in placenta
by: Michael Mortillo, et al.
Published: (2024-12-01)

On education /
by: 261065 Addams, Jane, et al.
Published: (1994)

Comprehensive mapping of 5-hydroxymethylcytosine epigenetic dynamics in axon regeneration
by: Yong-Hwee Eddie Loh, et al.
Published: (2017-02-01)

Comprehensive mapping of 5-hydroxymethylcytosine epigenetic dynamics in axon regeneration
by: Loh, Y, et al.
Published: (2017)

Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.
by: Kim, M, et al.
Published: (2016)

Development of an acoustic microscopy technique to assess particle distribution following needle-free injection
by: Condliffe, J, et al.
Published: (2006)

Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution
by: Liu, Y, et al.
Published: (2019)

5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages
by: Song, C, et al.
Published: (2017)

Robotic Rehabilitation and Transcranial Direct Current Stimulation in Children With Bilateral Cerebral Palsy
by: Liliane Raess, et al.
Published: (2022-02-01)

5-hydroxymethylcytosine marks regions with reduced mutation frequency
by: Schuster-Boeckler, P, et al.
Published: (2016)

Distinctive Patterns of 5-Methylcytosine and 5-Hydroxymethylcytosine in Schizophrenia
by: Jiaxiang Xie, et al.
Published: (2024-01-01)

Environmental Epigenetics and Genome Flexibility: Focus on 5-Hydroxymethylcytosine
by: Olga A. Efimova, et al.
Published: (2020-05-01)

Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis
by: Jianming Shao, et al.
Published: (2024-02-01)

International Union of Pure and Applied Chemistry. Division of Physical chemistry : Commission on Physicochemical Symbols, Terminology and symbols in physical chemistry /
by: Mill, Ian
Published: (1988)

Biodiversity Recording at Royal Botanic Garden Edinburgh
by: Robert Mill
Published: (2012-10-01)

Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells
by: Tekpli, X, et al.
Published: (2016)

Exploring the epigenetic landscape: The role of 5-hydroxymethylcytosine in neurodevelopmental disorders
by: Mohamed Adil Shah Khoodoruth, et al.
Published: (2024-01-01)

5-Methylcytosine and 5-Hydroxymethylcytosine Signatures Underlying Pediatric Cancers
by: Shalu Jhanwar, et al.
Published: (2019-05-01)

Profiling of oxBS-450K 5-hydroxymethylcytosine in human placenta and brain reveals enrichment at imprinted loci
by: Jose Ramon Hernandez Mora, et al.
Published: (2018-02-01)

TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia
by: Pérez, C, et al.
Published: (2012)